Completed EARLY_PHASE1 INTERVENTIONAL 4-arm NCT01511640

Behavioral Effects of Pregabalin and Cannabis

Behavioral Effects of Drugs (Outpatient)(43)

Sponsor: Joshua A. Lile, Ph.D.

Updated 11 times since 2017 Last updated: Aug 13, 2021 Started: Feb 1, 2017 Primary completion: Mar 15, 2020 Completion: Mar 15, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Cannabis-use Disorders and is currently completed. Joshua A. Lile, Ph.D. leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2023 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Dec 2022 — Jan 2023 [monthly]

Completed EARLY_PHASE1
Oct 2021 — Dec 2022 [monthly]

Completed EARLY_PHASE1

Status: Recruiting → Completed

▶ Show 6 earlier versions

Jan 2021 — Oct 2021 [monthly]

Recruiting EARLY_PHASE1
Jul 2020 — Jan 2021 [monthly]

Recruiting EARLY_PHASE1
Jun 2019 — Jul 2020 [monthly]

Recruiting EARLY_PHASE1
Jun 2018 — Jun 2019 [monthly]

Recruiting EARLY_PHASE1
Feb 2017 — Jun 2018 [monthly]

Recruiting EARLY_PHASE1

Status: Not Yet Recruiting → Recruiting · Phase: Phase 0 → EARLY_PHASE1
Jan 2017 — Feb 2017 [monthly]

Not Yet Recruiting Phase 0

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Joshua A. Lile, Ph.D.

Data source: University of Kentucky

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lexington, United States